Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Vadastuximab talirine

😃Good
Catalog No. T9901A-030Cas No. 1436390-64-5
Alias SGN-CD33A, 33A

Vadastuximab talirine is an antibody-drug conjugate (ADC) that can be used in life science related research. The CAS number is 1436390-64-5.

Vadastuximab talirine

Vadastuximab talirine

😃Good
Catalog No. T9901A-030Alias SGN-CD33A, 33ACas No. 1436390-64-5
Vadastuximab talirine is an antibody-drug conjugate (ADC) that can be used in life science related research. The CAS number is 1436390-64-5.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Vadastuximab talirine is an antibody-drug conjugate (ADC) that can be used in life science related research. The CAS number is 1436390-64-5.
SynonymsSGN-CD33A, 33A
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
Endotoxin< 1.0 EU/mg
Antigen Details
TargetCD33
Chemical Properties
Cas No.1436390-64-5
Storage & Solubility Information
Storage-20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Vadastuximab talirine | purchase Vadastuximab talirine | Vadastuximab talirine cost | order Vadastuximab talirine